Clinical Trial Update: Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating pegylated interferon alfa-2b with ribavirin in liver transplant recipients with chronic Hepatitis C recurrence; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Cirrhosis

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Liver Transplantation, Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2010-07-16